Cited by 87Genomic variations and chromosomal abnormalitiesGenetics and Neurodevelopmental DisordersGenetic Associations and Epidemiology

Association of Copy Number Variation of the 15q11.2 BP1-BP2 Region With Cortical and Subcortical Morphology and Cognition

Open access
Writing Committee for the ENIGMA-CNV Working Group, van der Meer, Dennis, Sønderby, Ida E., Kaufmann, Tobias, Walters, G. Bragi, Abdellaoui, Abdel, Ames, David, Amunts, Katrin +125 more·2020·JAMA Psychiatry

Abstract

Importance: Recurrent microdeletions and duplications in the genomic region 15q11.2 between breakpoints 1 (BP1) and 2 (BP2) are associated with neurodevelopmental disorders. These structural variants are present in 0.5% to 1.0% of the population, making 15q11.2 BP1-BP2 the site of the most prevalent known pathogenic copy number variation (CNV). It is unknown to what extent this CNV influences brain structure and affects cognitive abilities. Objective: To determine the association of the 15q11.2 BP1-BP2 deletion and duplication CNVs with cortical and subcortical brain morphology and cognitive task performance. Design, Setting, and Participants: In this genetic association study, T1-weighted brain magnetic resonance imaging were combined with genetic data from the ENIGMA-CNV consortium and the UK Biobank, with a replication cohort from Iceland. In total, 203 deletion carriers, 45 247 noncarriers, and 306 duplication carriers were included. Data were collected from August 2015 to April 2019, and data were analyzed from September 2018 to September 2019. Main Outcomes and Measures: The associations of the CNV with global and regional measures of surface area and cortical thickness as well as subcortical volumes were investigated, correcting for age, age2, sex, scanner, and intracranial volume. Additionally, measures of cognitive ability were analyzed in the full UK Biobank cohort. Results: Of 45 756 included individuals, the mean (SD) age was 55.8 (18.3) years, and 23 754 (51.9%) were female. Compared with noncarriers, deletion carriers had a lower surface area (Cohen d = -0.41; SE, 0.08; P = 4.9 × 10-8), thicker cortex (Cohen d = 0.36; SE, 0.07; P = 1.3 × 10-7), and a smaller nucleus accumbens (Cohen d = -0.27; SE, 0.07; P = 7.3 × 10-5). There was also a significant negative dose response on cortical thickness (β = -0.24; SE, 0.05; P = 6.8 × 10-7). Regional cortical analyses showed a localization of the effects to the frontal, cingulate, and parietal lobes. Further, cognitive ability was lower for deletion carriers compared with noncarriers on 5 of 7 tasks. Conclusions and Relevance: These findings, from the largest CNV neuroimaging study to date, provide evidence that 15q11.2 BP1-BP2 structural variation is associated with brain morphology and cognition, with deletion carriers being particularly affected. The pattern of results fits with known molecular functions of genes in the 15q11.2 BP1-BP2 region and suggests involvement of these genes in neuronal plasticity. These neurobiological effects likely contribute to the association of this CNV with neurodevelopmental disorders.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jamapsychiatry.2019.3779

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 46

  1. Redon R, Ishikawa S, Fitch KR, et al. Global variation in copy number in the human genome. Nature. 2006;444(7118):444-454. doi:10.1038/ nature05329 · DOI
  2. Girirajan S, Brkanac Z, Coe BP, et al. Relative burden of large CNVs on a range of neurodevelopmental phenotypes. PLoS Genet. 2011;7(11):e1002334. doi:10. 1371/journal.pgen.1002334 · DOI
  3. Cooper GM, Coe BP, Girirajan S, et al. A copy number variation morbidity map of developmental delay. Nat Genet. 2011;43(9):838-846. doi:10.1038/ ng.909 · DOI · Paper page
  4. Watson CT, Marques-Bonet T, Sharp AJ, Mefford HC. The genetics of microdeletion and microduplication syndromes: an update. Annu Rev Genomics Hum Genet. 2014;15:215-244. doi:10. 1146/annurev-genom-091212-153408 · DOI
  5. Rees E, Kendall K, Pardiñas AF, et al. Analysis of intellectual disability copy number variants for association with schizophrenia. JAMA Psychiatry. 2016;73(9):963-969. doi:10.1001/jamapsychiatry. 2016.1831 · DOI · Paper page
  6. Stefansson H, Meyer-Lindenberg A, Steinberg S, et al. CNVs conferring risk of autism or schizophrenia affect cognition in controls. Nature. 2014;505(7483):361-366. doi:10.1038/nature12818 · DOI · Paper page
  7. Crawford K, Bracher-Smith M, Owen D, et al. Medical consequences of pathogenic CNVs in adults: analysis of the UK Biobank. J Med Genet. 2019;56(3):131-138.
  8. Chai JH, Locke DP, Greally JM, et al. Identification of four highly conserved genes between breakpoint hotspots BP1 and BP2 of the Prader-Willi/Angelman syndromes deletion region that have undergone evolutionary transposition mediated by flanking duplicons. Am J Hum Genet. 2003;73(4):898-925. doi:10.1086/378816 · DOI · Paper page
  9. Goytain A, Hines RM, El-Husseini A, Quamme GA. NIPA1(SPG6), the basis for autosomal dominant form of hereditary spastic paraplegia, encodes a functional Mg2+ transporter. J Biol Chem. 2007;282(11): 8060-8068. doi:10.1074/jbc.M610314200 · DOI
  10. Goytain A, Hines RM, Quamme GA. Functional characterization of NIPA2, a selective Mg2+ transporter. Am J Physiol Cell Physiol. 2008;295(4): C944-C953. doi:10.1152/ajpcell.00091.2008 · DOI
  11. Napoli I, Mercaldo V, Boyl PP, et al. The fragile X syndrome protein represses activity-dependent translation through CYFIP1, a new 4E-BP. Cell. 2008; 134(6):1042-1054. doi:10.1016/j.cell.2008.07.031 · DOI · Paper page
  12. van der Zwaag B, Staal WG, Hochstenbach R, et al. A co-segregating microduplication of chromosome 15q11.2 pinpoints two risk genes for autism spectrum disorder. Am J Med Genet B Neuropsychiatr Genet. 2010;153B(4):960-966. doi:10.1002/ajmg.b.31055 · DOI · Paper page
  13. Mohan KN, Cao Y, Pham J, et al. Phenotypic association of 15q11.2 CNVs of the region of breakpoints 1-2 (BP1-BP2) in a large cohort of samples referred for genetic diagnosis. J Hum Genet. 2019;64 (3):253-255. doi:10.1038/s10038-018-0543-7 · DOI
  14. Stefansson H, Rujescu D, Cichon S, et al; Genetic Risk and Outcome in Psychosis. Large recurrent microdeletions associated with schizophrenia. Nature. 2008;455(7210):232-236. doi:10.1038/nature07229 · DOI · Paper page
  15. Burnside RD, Pasion R, Mikhail FM, et al. Microdeletion/microduplication of proximal 15q11.2 between BP1 and BP2: a susceptibility region for neurological dysfunction including developmental and language delay. Hum Genet. 2011;130(4):517-528. doi:10.1007/s00439-011-0970-4 · DOI · Paper page
  16. Silva AI, Ulfarsson MO, Stefansson H, et al. Reciprocal white matter changes associated with copy number variation at 15q11.2 BP1-BP2: a diffusion tensor imaging study. Biol Psychiatry. 2019;85(7): 563-572. doi:10.1016/j.biopsych.2018.11.004 · DOI · Paper page
  17. Winkler AM, Greve DN, Bjuland KJ, et al. Joint analysis of cortical area and thickness as a replacement for the analysis of the volume of the cerebral cortex. Cereb Cortex. 2018;28(2):738-749. doi:10.1093/cercor/bhx308 · DOI
  18. Thompson PM, Stein JL, Medland SE, et al; Alzheimer's Disease Neuroimaging Initiative, EPIGEN Consortium, IMAGEN Consortium, Saguenay Youth Study (SYS) Group. The ENIGMA consortium: large-scale collaborative analyses of neuroimaging and genetic data. Brain Imaging Behav. 2014;8(2):153-182. doi:10.1007/s11682-013-9269-5 · DOI · Paper page
  19. Sudlow C, Gallacher J, Allen N, et al. UK Biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015;12(3):e1001779. doi:10.1371/journal.pmed.1001779 · DOI · Paper page
  20. Wang K, Li M, Hadley D, et al. PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. Genome Res. 2007;17(11):1665-1674. doi:10.1101/gr.6861907 · DOI · Paper page
  21. Sønderby IE, Gústafsson Ó, Doan NT, et al; 16p11.2 European Consortium, for the ENIGMA-CNV working group. Dose response of the 16p11.2 distal copy number variant on intracranial volume and basal ganglia [published online October 3, 2018]. Mol Psychiatry. doi:10.1038/s41380-018-0118-1 · DOI · Paper page
  22. Morris DW, Pearson RD, Cormican P, et al; International Schizophrenia Consortium, SGENE+ Consortium; Wellcome Trust Case Control Consortium 2. An inherited duplication at the gene p21 protein-activated kinase 7 (PAK7) is a risk factor for psychosis. Hum Mol Genet. 2014;23(12): 3316-3326. doi:10.1093/hmg/ddu025 · DOI · Paper page
  23. Lemaitre H, Goldman AL, Sambataro F, et al. Normal age-related brain morphometric changes: nonuniformity across cortical thickness, surface area and gray matter volume? Neurobiol Aging. 2012;33(3):617.e1-617.e9. doi:10.1016/j.neurobiolaging. 2010.07.013 · DOI
  24. Panizzon MS, Fennema-Notestine C, Eyler LT, et al. Distinct genetic influences on cortical surface area and cortical thickness. Cereb Cortex. 2009;19 (11):2728-2735. doi:10.1093/cercor/bhp026 · DOI · Paper page
  25. Winkler AM, Kochunov P, Blangero J, et al. Cortical thickness or grey matter volume? the importance of selecting the phenotype for imaging genetics studies. Neuroimage. 2010;53(3):1135-1146. doi:10.1016/j.neuroimage.2009.12.028 · DOI · Paper page
  26. Hogstrom LJ, Westlye LT, Walhovd KB, Fjell AM. The structure of the cerebral cortex across adult life: age-related patterns of surface area, thickness, and gyrification. Cereb Cortex. 2013;23(11):2521-2530. doi:10.1093/cercor/bhs231 · DOI
  27. White T, Su S, Schmidt M, Kao C-Y, Sapiro G. The development of gyrification in childhood and adolescence. Brain Cogn. 2010;72(1):36-45. doi:10. 1016/j.bandc.2009.10.009 · DOI
  28. Tamnes CK, Herting MM, Goddings A-L, et al. Development of the cerebral cortex across adolescence: a multisample study of inter-related longitudinal changes in cortical volume, surface area, and thickness. J Neurosci. 2017;37(12): 3402-3412. doi:10.1523/JNEUROSCI.3302-16.2017 · DOI · Paper page
  29. Murre JMJ, Sturdy DPF. The connectivity of the brain: multi-level quantitative analysis. Biol Cybern. 1995;73(6):529-545. doi:10.1007/BF00199545 · DOI
  30. Raznahan A, Shaw P, Lalonde F, et al. How does your cortex grow? J Neurosci. 2011;31(19):7174-7177. doi:10.1523/JNEUROSCI.0054-11.2011 · DOI · Paper page
  31. Seldon HL. Does brain white matter growth expand the cortex like a balloon? hypothesis and consequences. Laterality. 2005;10(1):81-95. doi:10. 1080/13576500342000310 · DOI
  32. Natu VS, Gomez J, Barnett M, et al. Apparent thinning of visual cortex during childhood is associated with myelination, not pruning [published online July 13, 2018]. bioRxiv. doi:10. 1101/368274 · DOI
  33. Silva AI, Haddon JE, Ahmed Syed Y, et al. CYFIP1 haploinsufficient rats show white matter changes, myelin thinning, abnormal oligodendrocytes and behavioural inflexibility. Nat Commun. 2019;10(1):3455. doi:10.1038/s41467-019-11119-7 · DOI · Paper page
  34. Rimol LM, Hartberg CB, Nesvåg R, et al. Cortical thickness and subcortical volumes in schizophrenia and bipolar disorder. Biol Psychiatry. 2010;68(1):41-50. doi:10.1016/j.biopsych.2010. 03.036 · DOI
  35. Schenck A, Bardoni B, Langmann C, Harden N, Mandel J-L, Giangrande A. CYFIP/Sra-1 controls neuronal connectivity in Drosophila and links the Rac1 GTPase pathway to the fragile X protein. Neuron. 2003;38(6):887-898. doi:10.1016/S0896-6273(03) 00354-4 · DOI · Paper page
  36. Wang X, Shaw WR, Tsang HTH, Reid E, O'Kane CJ. Drosophila spichthyin inhibits BMP signaling and regulates synaptic growth and axonal microtubules. Nat Neurosci. 2007;10(2):177-185. doi:10.1038/nn1841 · DOI
  37. Woo YJ, Wang T, Guadalupe T, et al. A common CYFIP1 variant at the 15q11.2 disease locus is associated with structural variation at the language-related left supramarginal gyrus. PLoS One. 2016;11(6):e0158036. doi:10.1371/journal.pone. 0158036 · DOI
  38. Nakatani J, Tamada K, Hatanaka F, et al. Abnormal behavior in a chromosome-engineered mouse model for human 15q11-13 duplication seen in autism. Cell. 2009;137(7):1235-1246. doi:10.1016/ j.cell.2009.04.024 · DOI · Paper page
  39. Warland A, Kendall KM, Rees E, Kirov G, Caseras X. Schizophrenia-associated genomic copy number variants and subcortical brain volumes in the UK Biobank [published online January 24, 2019]. Mol Psychiatry. doi:10.1038/s41380-019-0355-y · DOI
  40. Rinaldi A, Oliverio A, Mele A. Spatial memory, plasticity and nucleus accumbens. Rev Neurosci. 2012; 23(5-6):527-541. doi:10.1515/revneuro-2012-0070 · DOI
  41. Babbs RK, Ruan QT, Kelliher JC, et al. CYFIP1 haploinsufficiency increases compulsive-like behavior and paternally inherited palatable food intake: implications for Prader-Willi Syndrome [published online February 14, 2018]. bioRxiv. doi:10.1101/264846 · DOI
  42. Flores G, Alquicer G, Silva-Gómez AB, et al. Alterations in dendritic morphology of prefrontal corticalandnucleusaccumbensneuronsinpost-pubertal rats after neonatal excitotoxic lesions of the ventral hippocampus. Neuroscience. 2005;133(2):463-470. doi:10.1016/j.neuroscience.2005.02.021 · DOI
  43. Huguet G, Schramm C, Douard E, et al; IMAGEN Consortium. Measuring and estimating the effect sizes of copy number variants on general intelligence in community-based samples. JAMA Psychiatry. 2018;75(5):447-457. doi:10.1001/ jamapsychiatry.2018.0039 · DOI · Paper page
  44. Fry A, Littlejohns TJ, Sudlow C, et al. Comparison of sociodemographic and health-related characteristics of UK Biobank participants with those of the general population. Am J Epidemiol. 2017;186(9):1026-1034. doi:10. 1093/aje/kwx246 · DOI · Paper page
  45. Jensen M, Girirajan S. An interaction-based model for neuropsychiatric features of copy-number variants. PLoS Genet. 2019;15(1): e1007879. doi:10.1371/journal.pgen.1007879 · DOI
  46. Männik K, Mägi R, Macé A, et al. Copy number variations and cognitive phenotypes in unselected populations. JAMA. 2015;313(20):2044-2054. doi:10.1001/jama.2015.4845 · DOI

Cited by

Sorted by citations

Authors
Writing Committee for the ENIGMA-CNV Working Group, van der Meer, D., Sønderby, I. E., Kaufmann, T., Walters, G. B., Abdellaoui, A., Ames, D., Amunts, K., Andersson, M., Armstrong, N. J., Bernard, M., Blackburn, N. B., Blangero, J., Boomsma, D. I., Brodaty, H., Brouwer, R. M., Bülow, R., Cahn, W., Calhoun, V. D., Caspers, S., Cavalleri, G. L., Ching, C. R. K., Cichon, S., Ciufolini, S., Corvin, A., Crespo-Facorro, B., Curran, J. E., Dalvie, S., Dazzan, P., de Geus, E. J. C., de Zubicaray, G. I., de Zwarte, S. M. C., Delanty, N., den Braber, A., Desrivieres, S., Di Forti, M., Doherty, J. L., Donohoe, G., Ehrlich, S., Eising, E., Espeseth, T., Fisher, S. E., Fladby, T., Frei, O., Frouin, V., Fukunaga, M., Gareau, T., Glahn, D. C., Grabe, H. J., Groenewold, N. A., Gústafsson, Ó., Haavik, J., Haberg, A. K., Hashimoto, R., Hehir-Kwa, J. Y., Hibar, D. P., Hillegers, M. H. J., Hoffmann, P., Holleran, L., Hottenga, J.-J., Hulshoff Pol, H. E., Ikeda, M., Jacquemont, S., Jahanshad, N., Jockwitz, C., Johansson, S., Jönsson, E. G., Kikuchi, M., Knowles, E. E. M., Kwok, J. B., Le Hellard, S., Linden, D. E. J., Liu, J., Lundervold, A., Lundervold, A. J., Martin, N. G., Mather, K. A., Mathias, S. R., McMahon, K. L., McRae, A. F., Medland, S. E., Moberget, T., Moreau, C., Morris, D. W., Mühleisen, T. W., Murray, R. M., Nordvik, J. E., Nyberg, L., Olde Loohuis, L. M., Ophoff, R. A., Owen, M. J., Paus, T., Pausova, Z., Peralta, J. M., Pike, B., Prieto, C., Quinlan, E. B., Reinbold, C. S., Reis Marques, T., Rucker, J. J. H., Sachdev, P. S., Sando, S. B., Schofield, P. R., Schork, A. J., Schumann, G., Shin, J., Shumskaya, E., Silva, A. I., Sisodiya, S. M., Steen, V. M., Stein, D. J., Strike, L. T., Tamnes, C. K., Teumer, A., Thalamuthu, A., Tordesillas-Gutiérrez, D., Uhlmann, A., Úlfarsson, M. Ö., van ’t Ent, D., van den Bree, M. B. M., Vassos, E., Wen, W., Wittfeld, K., Wright, M. J., Zayats, T., Dale, A. M., Djurovic, S., Agartz, I., Westlye, L. T., Stefánsson, H., Stefánsson, K., Thompson, P. M., & Andreassen, O. A.
Affiliations
  • Norwegian Centre for Mental Disorders Research, Division of Mental Health and Addiction, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway
  • Oslo University Hospital (NO)
  • deCODE Genetics (Iceland) (IS)
  • Amsterdam University Medical Centers (NL)
  • The University of Melbourne (AU)
  • Forschungszentrum Jülich (DE)
  • Umeå University (SE)
  • Murdoch University (AU)
  • Hospital for Sick Children (CA)
  • The University of Texas Rio Grande Valley (US)
  • Amsterdam Neuroscience (NL)
  • UNSW Sydney (AU)
  • University Medical Center Utrecht (NL)
  • Universitätsmedizin Greifswald (DE)
  • Georgia Institute of Technology (US)
  • Royal College of Surgeons in Ireland (IE)
  • University of Southern California (US)
  • King's College London (GB)
  • Trinity College Dublin (IE)
  • University Hospital Marqués de Valdecilla, IdahoIVAL, Centre de Investigación Biomédica en Red Salud Mental (CIBERSAM), Santander, Spain
  • University of Cape Town (ZA)
  • Department of Biological Psychology and Netherlands Twin Register, VU University Amsterdam, Amsterdam, the Netherlands
  • Faculty of Health and Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Australia
  • Department of Psychiatry, UMC Brain Center, University Medical Center Utrecht, Utrecht, the Netherlands
  • Beaumont Hospital (IE)
  • Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, United Kingdom
  • Cardiff University (GB)
  • Ollscoil na Gaillimhe – University of Galway (IE)
  • Technische Universität Dresden (DE)
  • Max Planck Institute for Psycholinguistics (NL)
  • University of Oslo (NO)
  • Radboud University Nijmegen (NL)
  • Commissariat à l'Énergie Atomique et aux Énergies Alternatives (FR)
  • The Graduate University for Advanced Studies, SOKENDAI (JP)
  • Boston Children's Hospital (US)
  • Haukeland University Hospital (NO)
  • Norwegian University of Science and Technology (NO)
  • National Center of Neurology and Psychiatry (JP)
  • Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands
  • Genentech (US)
  • Erasmus MC (NL)
  • University of Bonn (DE)
  • Fujita Health University (JP)
  • Centre Hospitalier Universitaire Sainte-Justine (CA)
  • The University of Osaka (JP)
  • The University of Sydney (AU)
  • Norwegian Centre for Mental Disorders Research, Department of Clinical Science, University of Bergen, Bergen, Norway
  • Maastricht University (NL)
  • QIMR Berghofer Medical Research Institute (AU)
  • Queensland University of Technology (AU)
  • The University of Queensland (AU)
  • CatoSenteret (NO)
  • Center for Neurobehavioral Genetics, University of California, Los Angeles
  • University of California, Los Angeles (US)
  • Bloorview Research Institute, Holland Bloorview Kids Rehabilitation Hospital, Toronto, Ontario, Canada
  • Research Institute, Hospital for Sick Children, Toronto, Ontario, Canada
  • Department of Radiology, University of Calgary, Calgary, Alberta, Canada
  • Universidad de Salamanca (ES)
  • Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, United Kingdom
  • Institute for Biological Psychiatry, Roskilde, Denmark
  • Centre for Population Neuroscience and Precision Medicine, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, United Kingdom
  • University of Toronto (CA)
  • UCL Queen Square Institute of Neurology (GB)
  • South African Medical Research Council (ZA)
  • Neuroimaging Unit, Technological Facilities, Valdecilla Biomedical Research Institute, IdahoIVAL, Santander, Spain
  • deCODE Genetics, Reykjavík, Iceland
  • MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, United Kingdom
  • National Health Service (GB)
  • Broad Institute (US)
  • University of California San Diego (US)
Corresponding author
  • Sønderby, Ida E.
  • Andreassen, Ole A.
ORCID
Venue
JAMA Psychiatry
Published
2020-04-01
Volume
77
Issue
4
Pages
420
ISSN
2168-622X (ISSN-L)
OpenAlex
W2982381555
Cited by
87
References
9
Citations by year
2026: 10 · 2025: 9 · 2024: 14 · 2023: 12 · 2022: 10 · 2021: 16 · 2020: 15 · 2019: 1
FWCI
6.33
Type
journal article
Language
en
Open access
Licence
other-oa
Locations
  • JAMA Psychiatry (publishedVersion, other-oa)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Research Publications (Maastricht University) (publishedVersion, other-oa)
  • VU Research Portal (publishedVersion, other-oa)
  • QUT ePrints (Queensland University of Technology) (submittedVersion, cc-by-nc)
  • UTAS Research Repository (submittedVersion)
  • ScholarWorks @ UTRGV (The University of Texas Rio Grande Valley) (submittedVersion)
  • DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
  • Figshare (submittedVersion)
  • Amsterdam UMC (VU Amsterdam) - Institutional Repository (submittedVersion, other-oa)
  • MPG.PuRe (Max Planck Society) (submittedVersion, other-oa)
  • Radboud Repository (Radboud University) (submittedVersion)
  • Research Publications (Maastricht University) (submittedVersion, other-oa)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
Funders
  • Biogen
  • University of Southern California
  • Stiftelsen Kristian Gerhard Jebsen (223273)
  • Universität Basel
  • Norges Teknisk-Naturvitenskapelige Universitet
  • Fondation Brain Canada
  • National Alliance for Research on Schizophrenia and Depression
  • National University of Ireland
  • Wellcome Trust
  • Neuroscience Research Australia
  • Royal College of Surgeons in Ireland
  • Amsterdam University Medical Centers
  • National Institute for Health and Care Research (CS-2017-17-007)
  • King's College London
  • University of Oxford
  • European Commission (609020)
  • Cardiff University
  • Science Foundation Ireland
  • University of Galway
  • Trinity College Dublin
  • Queensland University of Technology
  • ZonMw
  • Radboud Universiteit
  • Technische Universität Dresden
  • Astellas Pharma
  • Universitetet i Bergen
  • Deutsches Zentrum für Neurodegenerative Erkrankungen
  • Universitetet i Oslo
  • Norges Forskningsråd (276082, 223273)
  • Commissariat à l'Énergie Atomique et aux Énergies Alternatives
  • Centro de Investigación Biomédica en Red de Salud Mental
  • University of Cape Town
  • RWTH Aachen University
  • Université Paris-Saclay
  • Fujita Health University
  • Rheinische Friedrich-Wilhelms-Universität Bonn
  • National Center of Neurology and Psychiatry
  • Haukeland Universitetssjukehus
  • Akershus Universitetssykehus
  • H. Lundbeck A/S
  • Vincent Fairfax Family Foundation
  • Amsterdam Neuroscience
  • Max Planck Instituut voor Psycholinguïstiek
  • National Institutes of Health (223273, U54 EB20403)
  • Genentech
  • University of California, Los Angeles
  • Institute of Psychiatry, Psychology and Neuroscience, King’s College London
  • Canadian Institutes of Health Research
  • Medical Research Council (MC_PC_17228, MR/L010305/1, MR/N000390/1)
  • National Health and Medical Research Council
  • Japan Society for the Promotion of Science (18KT0022, 20H03611, 17K15049, 16H03305, 20K15778)
  • Helse Sør-Øst RHF (R01MH116147, R56AG058854, 223273)
  • School of Psychology, Cardiff University
  • National Institute on Aging (R56AG058854, T32AG058507)
  • National Institute of Mental Health (R01MH116147)
  • National Institute of Biomedical Imaging and Bioengineering (U54EB020403)
  • National Institute for Physiological Sciences
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
Keywords
copy number variation, microdeletion, microduplication, cortical thickness, cortical surface area, subcortical volume, nucleus accumbens, brain structure, cognitive ability, neurodevelopmental disorders, dose-response relationship, structural variants, brain imaging genetics, UK Biobank
MeSH terms
Brain Cortical Thickness, Cerebral Cortex, Chromosomes, Human, Pair 15, Cognition, Female, Heterozygote, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Neuropsychological Tests, Organ Size, Genetic Association Studies, Chromosome Breakpoints, DNA Copy Number Variations, Neuroimaging

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review